Led by Co-Founder Jon McNeill – co-founder of DVx Ventures and former President of Tesla – and CEO Adam Patti – Former Founder and CEO of IndexIQ Focused on solving the major issues with existing...
CALGARY, Alberta, June 18, 2010 (GLOBE NEWSWIRE) -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Antares Pharma, Inc...
BOCA RATON, Fla., March 16 /PRNewswire/ -- Dawson James Securities, a full-service investment firm covering the healthcare and biotechnology industry, issued an upgrade report raising their...
American Stock Exchange Lists Common Stock of Antares Pharma, Inc. NEW YORK, Sept. 23 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed the common stock of Antares Pharma...
Antares Pharma's (OTCBB: ANTR / Amex: AIS as of September 23, 2004) North American Licensee BioSante Pharmaceuticals, Inc. Announces Positive Results of Phase II Study of LibiGel(TM), Topical...
RNS Number:2878U Alternative Invest. Strategies Ld 15 January 2004 The unaudited net asset value per ordinary and redeemable ordinary share of the Alternative Investment Strategies Limited...
RNS Number:6615T Alternative Invest. Strategies Ld 24 December 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company Alternative Investment Strategies...
RNS Number:4980T Alternative Invest. Strategies Ld 19 December 2003 ALTERNATIVE INVESTMENT STRATEGIES LIMITED PRELIMINARY ANNOUNCEMENT OF THE FINAL RESULTS The Directors announce...
RNS Number:2205T Alternative Invest. Strategies Ld 12 December 2003 The unaudited net asset value per ordinary and redeemable ordinary share of the Alternative Investment Strategies Limited...
RNS Number:8768S Alternative Invest. Strategies Ld 04 December 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company Alternative Investment Strategies...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
4 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
12 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
26 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
52 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
156 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
260 | 0 | 0 | 1.62 | 1.62 | 1.62 | 0 | 0 | SP |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales